Kindai University · Faculty of Medicine

Research keywords肺癌・分子標的治療薬・呼吸器外科・MET exon 14 skipping・HER2 mutation・EGFR exon20 insertion・KRAS G12C inhibitor・acquired resistance

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Effects of secondary EGFR mutations on resistance against upfront osimertinib in cells with EGFR-activating mutations in vitro.
• Secondary mutations of the EGFR gene that confer resistance to mobocertinib in EGFR exon 20 insertion.
• [A Case of Curatively Resected Locally Advanced Cancer of the Pancreatic Body Treated by Distal Pancreatectomy with En Bloc Celiac Axis Resection after Preoperative Intensive Treatment].
• Life-threatening complications after pulmonary resection for lung cancer in patients on chronic hemodialysis.

• MET遺伝子のエクソン14欠失変異を有する肺腺癌に対する分子標的治療
• EGFRエクソン20挿入変異陽性肺がんに対する治療戦略の新展開

• Official profile